Gland pharma nse
WebApr 11, 2024 · NSE BSE Open Trading Account Gland Pharma Ltd. Sector: Pharmaceuticals & Drugs Add to 1,245.80 21.25 (1.74%) As on 22 Mar, 2024 03:57 … WebFor Gland Pharma Limited P Sampath Kumar Company Secretary and Compliance Officer . GLAND PHARMA LIMITED BSE Script Code: 543245 NSE Symbol: GLAND ISIN; INE068V0I023 COMPLIANCE CERTIFICATE For the Year Ended on 31 st March 2024 [Pursuant to Regulation 7(3) of the SEBI (Listing Obligations anrl Disclosure
Gland pharma nse
Did you know?
WebGland Pharma Stock Price Analysis and Quick Research Report. Is Gland Pharma an attractive stock to invest in? The Indian healthcare sector is expected to reach US$ 372 … WebOct 27, 2024 · Shares of Gland Pharma hit a 52-week low of Rs 1,942.90 as they plunged 13 per cent on the BSE in Thursday’s intra-day trade after the company reported a 20.14 per cent year-on-year (YoY) decline in i TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH. Subscribe To Insights
WebNov 9, 2024 · Gland Pharma IPO - Read Gland Pharma IPO Review and Analysis on The Economic Times. Find out Gland Pharma IPO Issue Price, Subscription Dates and Status, Gland Pharma IPO Listing Date and more. ... Date Sources:Live BSE and NSE Quotes Service: TickerPlant Corporate Data, F&O Data & Historical price volume data: Dion … WebGland Pharma Investment Stock Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral …
WebApr 1, 2024 · NSE India (National Stock Exchange) - LIVE stock/share market updates from one of the leading stock exchange. Current stock/share market news, real-time … WebApr 12, 2024 · Gland Pharma Ltd. BSE: 543245, NSE: GLAND Market Capitalisation ₹21,135 Cr 12 Month Earnings ₹988 Cr Price to Earnings 21.39 Overview Key Ratios Peer Comparison Financials Share Holdings News Other details ₹1,282.20 As on 24-Mar-2024 IST ₹-1.90 • -0.15 % Prev Close ₹ 1,284.10 Day's Open ₹ 1,275.00 Today's High ₹ …
WebMay 17, 2024 · Consolidated revenue from operations for the financial year ended March 2024 was Rs 3,462.9 crore. It was Rs 2,633.2 crore in the preceding fiscal. NEW DELHI: Drug firm Gland Pharma on Monday reported a 34 per cent rise in its consolidated net profit to Rs 260.4 crore for the fourth quarter ended March 2024, on account of robust sales.
WebApr 13, 2024 · Gland Pharma Ltd. delivery percentage and volume analysis and insights for the period of to 09 Apr 2024 on NSE Delivery percentage and volume analysis - Gland … mount and blade controllerWebApr 12, 2024 · Gland Pharma Limited, a generic injectable-focused company, engages in the development, manufacture, sale, and distribution of pharmaceuticals. The company’s … mount and blade clash of kingsWebApr 12, 2024 · Gland Pharma Ltd is in the Pharmaceuticals sector with the Market Capitalization of worth Rs. 67,419.04 crores, it is incorporated in the year 1978. It has … mount and blade cheats xbox 1WebNov 30, 2024 · Gland Pharma stock has tanked 53 per cent in 2024 so far. At current level, the company has a market cap of Rs 29.64 thousand crore. The stock's 52-week range is Rs 4,062.95 - Rs 1,660.00. Click Here For Latest Updates On Stock Market Zee Business Live mount and blade controller supportWeb1 day ago · Sotac Pharmaceuticals Ltd Share Price, Stock Price Live NSE, BSE Today News MARKETS Sotac Pharmaceuticals Ltd NIFTY 50 17,599.15 42.10 (0.24%) SENSEX 59,832.97 143.66 (0.24%) Dow Jones 33,485.29... mount and blade change battle sizeWebStock of Gland Pharma (GLAND) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher! My analysis of Gland Pharma is bullish for shortterm, and stock might move up till 1297.6 or till 1345.5. heartburn medication generic zantacWebMay 18, 2024 · Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 46914.36 Crore) operating in Pharmaceuticals sector. Agencies Promoters held 58.3 per cent stake in the company as of March 31, 2024, while FIIs held 11.9 per cent, DIIs 11.3 per cent and public and others 18.6 per cent. heartburn medication dementia